Nipah Virus Infection

Virus

ssRNA(-), Paramyxoviridae, genus Henipavirus. Recurrent outbreaks India (Kerala) + Bangladesh — regionally high-yield, emerging infection (unlike most long-endemic CNS topics here).

Reservoir/Transmission

Reservoir: Pteropus fruit bats (flying foxes). Routes:

Direct contact bat excreta/secretions
RAW DATE PALM SAP contaminated by bat saliva/urine (nocturnal collection, open containers) — key Bangladesh/India route
Intermediate host contact — PIGS (original 1998-99 Malaysia outbreak, pig farmers — how virus first recognized)
HUMAN-TO-HUMAN transmission (bodily fluid close contact) — well documented Bangladesh/Kerala outbreaks

KEY CONTRAST vs JE: JE humans = dead-end host (no further transmission); Nipah CAN transmit human-to-human → outbreak containment/healthcare-associated transmission = major public health concern.

Clinical

Febrile prodrome (fever, headache, myalgia) → ENCEPHALITIS in substantial proportion (altered consciousness, seizures, focal signs). CASE FATALITY: ~40-75% (outbreak-dependent) — substantially HIGHER than JE, among most lethal infections in curriculum. RESPIRATORY involvement (cough, distress, atypical pneumonia) — distinguishes from mostly-neurotropic-only CNS viruses in this section; also contributes to H2H transmission via resp secretions. Survivors: long-term neuro sequelae + RELAPSE ENCEPHALITIS (delayed recurrence months-years later, reactivation from latent CNS reservoir) — conceptually parallels SSPE’s delayed-consequence pattern (different mechanism).

Diagnosis

RT-PCR (resp secretions, CSF, urine) = primary acute method. Serology (IgM/IgG ELISA): supportive, later-course/epidemiological confirmation.

Management

SUPPORTIVE ONLY — no licensed specific antiviral or vaccine for humans. Heavy emphasis on OUTBREAK CONTROL: strict infection control/isolation (H2H risk), contact tracing, public health messaging (avoid raw date palm sap, reduce bat-human contact). WHO R&D Blueprint priority pathogen — high case fatality + spillover potential + demonstrated H2H transmissibility. Example of disease managed almost entirely via public health containment, not pharmacology.

The Virus and Its Regional Significance

Nipah virus is a single-stranded negative-sense RNA virus of the Paramyxoviridae family, genus Henipavirus — genuinely, specifically significant in this curriculum’s regional context given recurrent outbreaks in India, particularly Kerala, alongside Bangladesh, making it a real, high-yield emerging-infection topic distinct from most other CNS infections covered here, which are longer-established, endemic diseases.

Reservoir and Transmission — A Genuine Zoonotic Spillover Story

Fruit bats of the genus Pteropus (flying foxes) are the natural reservoir of Nipah virus, and transmission to humans occurs through several genuinely distinct, specifically testable routes: direct contact with bat excreta/secretions; consumption of raw date palm sap contaminated by bat saliva or urine during nocturnal sap collection (a specifically important, regionally relevant route in the Bangladesh and, to some extent, Indian outbreak pattern, reflecting the practice of collecting sap in open containers that bats can access and contaminate overnight); contact with infected intermediate hosts, classically pigs in the original 1998-99 Malaysian outbreak (which is, in fact, how the virus first came to be recognized, following an outbreak among pig farmers); and, genuinely importantly, human-to-human transmission via close contact with an infected patient’s bodily fluids, particularly well documented in the Bangladesh and Kerala outbreak patterns, and a real point of contrast worth remembering against Japanese Encephalitis’s genuinely dead-end human host status — Nipah virus, unlike JE, can transmit from human to human, making outbreak containment and healthcare-associated transmission a genuinely important, specific public-health concern.

Clinical Manifestations

Nipah virus infection presents with an initial nonspecific febrile prodrome (fever, headache, myalgia) progressing, in a substantial proportion of symptomatic cases, to encephalitis — altered consciousness, seizures, and focal neurological signs — with a genuinely, specifically high case fatality rate (historically cited in the range of roughly 40-75% depending on the specific outbreak, substantially higher than most other viral encephalitides covered in this curriculum, including Japanese Encephalitis), making Nipah virus genuinely one of the most lethal infections discussed in this entire curriculum. Respiratory involvement (cough, respiratory distress, sometimes atypical pneumonia) is also genuinely, specifically notable as a real feature of Nipah virus disease in a meaningful proportion of cases — a point of distinction from most of the other primarily-neurotropic viral CNS infections covered in this section, and one that additionally, practically, contributes to the human-to-human transmission risk via respiratory secretions. Survivors of acute encephalitis are genuinely at risk of long-term neurological sequelae, and, notably, relapse encephalitis — a delayed recurrence of neurological symptoms occurring months to years after apparent recovery from the acute illness, thought to reflect reactivation of virus that had persisted in a latent CNS reservoir — a genuinely distinctive, specifically testable point of similarity in broad concept (though not mechanism) to the delayed-CNS-consequence pattern already established for SSPE under Slow Virus Infections and Prion Diseases.

Diagnosis

RT-PCR on respiratory secretions, CSF, or urine is the primary, most sensitive acute diagnostic method; serology (IgM/IgG ELISA) supports diagnosis, particularly useful later in the course or for retrospective/epidemiological confirmation.

Management and Outbreak Control

Treatment is entirely supportive, since no specific antiviral therapy or vaccine is currently licensed/approved for human use against Nipah virus — a genuinely important point given the disease’s severity, and one that places heavy emphasis on outbreak control measures: strict infection control and isolation precautions for suspected/confirmed cases (given the genuine human-to-human transmission risk established above), contact tracing, and public health messaging around avoiding raw date palm sap consumption and reducing bat-human contact in endemic/outbreak-prone regions — Nipah virus is, genuinely, a real example in this curriculum of a disease managed almost entirely through public-health containment rather than any pharmacological intervention, reflecting its status as a priority pathogen under global epidemic-preparedness frameworks (WHO’s R&D Blueprint priority disease list) given its combination of high case fatality, spillover potential, and demonstrated human-to-human transmissibility.